logo
Lesser flamingos lose one of their only four African breeding sites to sewage

Lesser flamingos lose one of their only four African breeding sites to sewage

Yahoo7 days ago

By Tim Cocks
KIMBERLEY, South Africa (Reuters) -Until the last half-decade, the majestic lesser flamingo had four African breeding sites: two salt pans in Botswana and Namibia, a soda lake in Tanzania, and an artificial dam outside South Africa's historic diamond-mining town of Kimberley.
Now it only has three.
Years of raw sewage spilling into Kamfers Dam, the only South African water body where lesser flamingos congregated in large enough numbers to breed, have rendered the water so toxic that the distinctive pink birds have abandoned it, according to conservationists and a court judgment against the local council seen by Reuters.
Lesser flamingos are currently considered near-threatened, rather than endangered, by the International Union for Conservation of Nature: there are 2-3 million left, four-fifths of them spread across Africa, the rest in a smaller area of South Asia.
But they are in steep decline, and the poisoning of one of their last few breeding sites has worsened their plight dramatically.
Tania Anderson, a conservation biologist specialising in flamingos, told Reuters the IUCN was about to increase its threat-level to "vulnerable", meaning "at high risk of extinction in the wild", owing largely to their shrinking habitats of salty estuaries or soda lakes shallow enough for them to wade through.
"It's really very upsetting," Anderson said of the sewage spills in Kamfers Dam. "Flamingos play a pivotal role in maintaining the water ecosystems of our wetlands."
A 2021 study in Biological Conservation found sewage threatens aquatic ecosystems across a vast area of the planet. Although 200 nations came together at the U.N. COP16 biodiversity summit in Colombia last year to tackle threats to wildlife, no agreement was reached.
'THEY JUST DISAPPEARED'
Footage taken by the Wildlife and Environment Society of South Africa in May 2020 shows Kamfers Dam turned flamboyant pink with flamingos. When Reuters visited this month, there were none.
A closer look at the water revealed a green sludge that bubbled and stank of human waste.
"It was a sea of pink," Brenda Booth recalled, as she gazed over the bird-free lake located on the farm she owns, dotted with acacia trees and antelope.
"They all just disappeared," said Booth, who last month secured the court order compelling the African National Congress-run municipality in charge of Kimberley, a city of 300,000, to fix the problem.
Over the years, the treatment plant "became progressively dysfunctional to the point where ... approximately 36 megalitres a day of untreated sewage was being discharged into the dam," said Adrian Horwitz, the lawyer bringing the case in the High Court of South Africa, Northern Cape division.
Municipality manager Thapelo Matlala told Reuters thieves had vandalised the plant and stolen equipment, grinding it to a halt.
"We are working on a new strategy for ... repairing the damage," he said outside his office, adding that this needed 106 million rand ($5.92 million), money the council didn't have.
Failure to deliver services was one of the main reasons the ANC lost its 30-year-strong majority in last year's elections.
Lesser flamingos mostly eat spirulina, a blue-green algae - filtering it through their beaks. This limits them to alkaline water bodies, largely in East Africa's Rift Valley.
They're fussy about where they breed, with just three sites in India alongside the remaining three in Africa.
Flamingos began breeding at Kamfers Dam in 2006, said Ester van der Westhuizen-Coetzer, wetlands specialist for local diamond miner Ekapa Group, as she waded through grassland at the edge of another lake where she had spotted a flock.
In 2020, there were 71,000 on the dam, with up to 5,000 new chicks each season.
"They've missed three or four breeding seasons," she said, and many also died of botulism, a disease that flourishes in waste.
Sewage has become a problem across South Africa, where few treatment plants are in working order, and if nothing is done, "the whole system will degrade and blow up," she said.
"That will have a huge impact, and not only on flamingos."
($1 = 17.8903 rand)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bat-eared foxes return to zoo after 30 year wait
Bat-eared foxes return to zoo after 30 year wait

Yahoo

time2 hours ago

  • Yahoo

Bat-eared foxes return to zoo after 30 year wait

A zoo has welcomed two rare bat-eared foxes, 30 years on from when the animal was last there. The two African foxes, which are known for their 13cm (five inches) tall ears, are said to be settling in well at Chester Zoo. Sisters Maasai and Malindi will live alongside 12 porcupines in the zoo's new Heart of Africa habitat and will play a part in the zoo's conservation work. David White, Chester Zoo's team manager, said: "It's incredibly exciting to welcome bat-eared foxes back to Chester Zoo after a 30-year hiatus and they're a wonderful addition to our new Heart of Africa habitat." "They're a truly unique and fascinating species with some amazing adaptations," he added. He said their "enormous ears aren't just for show – they act like satellite dishes and help the foxes detect the tiniest of movements coming from insects beneath the ground, allowing them to detect prey with pinpoint accuracy". Zoo conservationists brought the sisters over to Chester from a zoo in Paris, France, with one of the sisters set to be introduced to a male fox as part of efforts to safeguard the little-known species. Bat-eared foxes were given their name due to their distinctive oversized ears and they are found in the open savannahs and arid grasslands of eastern and southern Africa. In the wild, bat-eared foxes face increasing threats, largely due to habitat loss caused by agriculture, human encroachment and hunting, a zoo spokesperson said. David White said that like many species found in the African savannah, bat-eared foxes were under threat as their habitat became more fragmented as a result of human activity. "That's why our teams are on the ground in several national parks across Kenya and Uganda safeguarding some of the continent's rarest species like northern giraffe, giant pangolins, mountain bongo and Eastern black rhino," he said. "By protecting these species and their habitats we're also helping many of Africa's little known species like bat-eared foxes, that share the same habitats, to go on to thrive once again." Read more stories from Cheshire on the BBC, watch BBC North West Tonight on BBC iPlayer and follow BBC North West on X. You can also send story ideas via Whatsapp to 0808 100 2230. 'Giraffes, zebras, antelopes and ostriches have become housemates' Breeding hope as rare fossa arrives at zoo from US Sloth has pioneering surgery to cure toothache Chester Zoo

Bat-eared foxes return to zoo after 30 year wait
Bat-eared foxes return to zoo after 30 year wait

Yahoo

time2 hours ago

  • Yahoo

Bat-eared foxes return to zoo after 30 year wait

A zoo has welcomed two rare bat-eared foxes, 30 years on from when the animal was last there. The two African foxes, which are known for their 13cm (five inches) tall ears, are said to be settling in well at Chester Zoo. Sisters Maasai and Malindi will live alongside 12 porcupines in the zoo's new Heart of Africa habitat and will play a part in the zoo's conservation work. David White, Chester Zoo's team manager, said: "It's incredibly exciting to welcome bat-eared foxes back to Chester Zoo after a 30-year hiatus and they're a wonderful addition to our new Heart of Africa habitat." "They're a truly unique and fascinating species with some amazing adaptations," he added. He said their "enormous ears aren't just for show – they act like satellite dishes and help the foxes detect the tiniest of movements coming from insects beneath the ground, allowing them to detect prey with pinpoint accuracy". Zoo conservationists brought the sisters over to Chester from a zoo in Paris, France, with one of the sisters set to be introduced to a male fox as part of efforts to safeguard the little-known species. Bat-eared foxes were given their name due to their distinctive oversized ears and they are found in the open savannahs and arid grasslands of eastern and southern Africa. In the wild, bat-eared foxes face increasing threats, largely due to habitat loss caused by agriculture, human encroachment and hunting, a zoo spokesperson said. David White said that like many species found in the African savannah, bat-eared foxes were under threat as their habitat became more fragmented as a result of human activity. "That's why our teams are on the ground in several national parks across Kenya and Uganda safeguarding some of the continent's rarest species like northern giraffe, giant pangolins, mountain bongo and Eastern black rhino," he said. "By protecting these species and their habitats we're also helping many of Africa's little known species like bat-eared foxes, that share the same habitats, to go on to thrive once again." Read more stories from Cheshire on the BBC, watch BBC North West Tonight on BBC iPlayer and follow BBC North West on X. You can also send story ideas via Whatsapp to 0808 100 2230. 'Giraffes, zebras, antelopes and ostriches have become housemates' Breeding hope as rare fossa arrives at zoo from US Sloth has pioneering surgery to cure toothache Chester Zoo

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk
Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

Yahoo

time14 hours ago

  • Yahoo

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death by half, a finding that could be practice changing, experts said on Sunday. The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test called a liquid biopsy to indicate the need for a change in treatment in women with a common form of breast cancer, even before tumor growth can be detected on imaging. The early switch approach in women with hormone receptor-positive, HER2-negative breast cancer resulted in a 56% reduction in the risk of disease progression or death, said Dr. Eleonora Teplinsky, an oncologist at Valley-Mount Sinai Comprehensive Cancer Care and an ASCO breast cancer expert. "When patients progress on scans, we're already behind," Teplinsky said at a media briefing. She said an early switch approach, before disease progression, allows doctors "to essentially stay ahead of the curve." Camizestrant is not yet FDA-approved, but Teplinsky said she believes the data will likely result in a new treatment paradigm. The trial involved 3,256 patients with advanced hormone receptor-positive, HER2-negative breast cancer, the most common type in which hormones such as estrogen fuel cancer growth. These cancers lack high levels of HER2, another cancer driver. Women in the trial had at least six months of treatment with aromatase inhibitors that block hormones fueling the cancer, as well as targeted drugs called CDK4/6 inhibitors such as Novartis' Kisqali, Pfizer's Ibrance or Eli Lilly's Verzenio, which block an enzyme that fuels cancer growth. About 40% of patients treated with aromatase inhibitors develop mutations in the estrogen receptor 1 gene called ESR1 mutations, a sign of early drug resistance. Camizestrant and similar drugs called selective estrogen receptor degraders, or SERDS, block estrogen receptor signaling in cancer cells. In the trial, researchers used blood tests to look for ESR1 mutations until 315 patients were identified. They were randomly assigned to either switch to camizestrant plus the CDK4/6 inhibitor or continue with standard treatment plus a placebo. The researchers found that it took 16 months for the disease to progress in women who got camizestrant, compared with 9.2 months in those who continued on standard therapy, a statistically significant difference in a measure known as progression-free survival. No new side effects were reported and few patients from either group dropped out due to side effects. "This is going to be very impactful for our patients," said Dr. Hope Rugo, head of breast medical oncology at City of Hope in Duarte, California. The question, she said, is how do doctors incorporate the testing into clinical practice. THE FUTURE OF CANCER TREATMENT AstraZeneca Chief Executive Pascal Soriot in a press briefing acknowledged that monitoring patients for drug resistance before cancer progresses would require a switch in practice, but said it represents the future of cancer treatment. "It will be complicated in the beginning," he said, "but over time, like everything else, we will manage to simplify it and it will become part of what people do." In a separate trial, adding AstraZeneca's immunotherapy Imfinzi to standard treatment before and after surgery in patients with early-stage stomach and esophageal cancers helped delay cancer progression or recurrence compared to chemotherapy alone. The global study of nearly 950 patients tested Imfinzi, known chemically as durvalumab, in combination with a chemotherapy regimen called FLOT given around the time of initial cancer surgery. The durvalumab plus FLOT combination led to a 29% reduction in disease recurrence, progression or death, referred to as event-free survival, compare with those who received the chemotherapy regimen alone. "We demonstrate that immunotherapy works in early-stage disease, which is great," lead study author Dr. Yelena Janjigian of Memorial Sloan Kettering Cancer Center in New York told reporters at the meeting. "We did not see any new safety signals, so this will change practice for our patients, which is exciting to see." Both studies were also published on Sunday in the New England Journal of Medicine.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store